Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Clinical trial NCT01996865 · COMPLETED
Trial details
- NCT number
- NCT01996865
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2024-05-11
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.